Cargando…

Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience

PURPOSE: To explore the benefit yielded by radiotherapy (RT), we report a series of metastatic renal cell carcinoma (RCC) patients treated with concomitant RT plus Nivolumab. METHODS/PATIENTS: Patients undergoing Nivolumab treatment plus concomitant RT (ablative or palliative) were included. RT was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francolini, Giulio, Campi, Riccardo, Di Cataldo, Vanessa, Detti, Beatrice, Loi, Mauro, Triggiani, Luca, La Mattina, Salvatore, Borghetti, Paolo, Magrini, Stefano Maria, Nicosia, Luca, Alongi, Filippo, Ghirardelli, Paolo, Vavassori, Vittorio, Allegra, Andrea Gaetano, Aquilano, Michele, Scoccimarro, Erika, Peruzzi, Anna, Pastina, Pierpaolo, Visani, Luca, Desideri, Isacco, Serni, Sergio, Meattini, Icro, Livi, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Brief Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9418086/ https://www.ncbi.nlm.nih.gov/pubmed/35739349 http://dx.doi.org/10.1007/s12094-022-02844-5

Ejemplares similares

Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
por: Francolini, Giulio, et al.
Publicado: (2022)

Impact of COVID-19 on workload burden of a complex radiotherapy facility
por: Francolini, Giulio, et al.
Publicado: (2021)

Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study
por: Triggiani, Luca, et al.
Publicado: (2017)

Efficacy and Tolerability of CyberKnife Stereotactic Robotic Radiotherapy for Primary or Secondary Orbital Lesions: A Single-Center Retrospective Experience
por: Desideri, Isacco, et al.
Publicado: (2019)

De-escalating postoperative radiation therapy after primary systemic therapy in cT1-2N1 breast cancer: lesson from the RAPCHEM/BOOG 2010-03 trial
por: Banini, Marco, et al.
Publicado: (2023)

Three Months’ PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy—STARR (NCT05455736)
por: Francolini, Giulio, et al.
Publicado: (2023)

Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results
por: Francolini, Giulio, et al.
Publicado: (2023)

Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique
por: Borghetti, Paolo, et al.
Publicado: (2016)

Recent advances in de-intensification of radiotherapy in elderly cancer patients
por: Desideri, Isacco, et al.
Publicado: (2020)

Reply to ‘Comment on ‘Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study’’
por: Triggiani, Luca, et al.
Publicado: (2018)

Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance
por: Triggiani, Luca, et al.
Publicado: (2021)

Integration between Novel Imaging Technologies and Modern Radiotherapy Techniques: How the Eye Drove the Chisel
por: Francolini, Giulio, et al.
Publicado: (2022)

Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility
por: Desideri, Isacco, et al.
Publicado: (2020)

Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility
por: Desideri, Isacco, et al.
Publicado: (2021)

Single-Fraction Radiotherapy (SFRT) For Bone Metastases: Patient Selection And Perspectives
por: Loi, Mauro, et al.
Publicado: (2019)

How Has Prostate Cancer Radiotherapy Changed in Italy between 2004 and 2011? An Analysis of the National Patterns-Of-Practice (POP) Database by the Uro-Oncology Study Group of the Italian Society of Radiotherapy and Clinical Oncology (AIRO)
por: Mazzeo, Ercole, et al.
Publicado: (2021)

Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic
por: Magrini, Stefano Maria, et al.
Publicado: (2020)

Postmastectomy Radiotherapy for Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy
por: Meattini, Icro, et al.
Publicado: (2014)

Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
por: Borghetti, Paolo, et al.
Publicado: (2022)

Multiple Cutaneous Angiosarcomas after Breast Conserving Surgery and Bilateral Adjuvant Radiotherapy: An Unusual Case and Review of the Literature
por: Meattini, Icro, et al.
Publicado: (2014)

Repeated stereotactic radiosurgery for the treatment of relapsed brain metastases: is it time to give up whole-brain radiotherapy?
por: Nicosia, Luca, et al.
Publicado: (2020)

Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894)
por: Meattini, Icro, et al.
Publicado: (2022)

The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature
por: Bruni, Alessio, et al.
Publicado: (2020)

ESTRO vision 2030: the young Italian Association of Radiotherapy and Clinical Oncology (yAIRO) commitment statement
por: De Felice, Francesca, et al.
Publicado: (2021)

RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment
por: Guerini, Andrea Emanuele, et al.
Publicado: (2022)

Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art
por: Desideri, Isacco, et al.
Publicado: (2020)

INTERACTS (INTErventional Radiotherapy ACtive Teaching School) consensus conference on sarcoma interventional radiotherapy (brachytherapy) endorsed by AIRO (Italian Association of Radiotherapy and Clinical Oncology)
por: Tagliaferri, Luca, et al.
Publicado: (2020)

Radiomics in the Setting of Neoadjuvant Radiotherapy: A New Approach for Tailored Treatment
por: Nardone, Valerio, et al.
Publicado: (2021)

Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis
por: Francolini, Giulio, et al.
Publicado: (2022)

Radiation therapy during the coronavirus disease 2019 (covid-19) pandemic in Italy: a view of the nation's young oncologists
por: Meattini, Icro, et al.
Publicado: (2020)

Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes
por: Barbera, F, et al.
Publicado: (2017)

Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)
por: Francolini, G., et al.
Publicado: (2021)

The Italian Association for Radiotherapy and Clinical Oncology (AIRO) position statements for postoperative breast cancer radiation therapy volume, dose, and fractionation
por: Meattini, Icro, et al.
Publicado: (2022)

Management of prostate cancer radiotherapy during the COVID-19 pandemic: A necessary paradigm change
por: Detti, Beatrice, et al.
Publicado: (2021)

Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature
por: Buglione, Michela, et al.
Publicado: (2013)

Can brachytherapy be properly considered in the clinical practice? Trilogy project: The vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group
por: Tagliaferri, Luca, et al.
Publicado: (2020)

Hypofractionation in Prostate Cancer: Radiobiological Basis and Clinical Appliance
por: Mangoni, M., et al.
Publicado: (2014)

Non-Oncological Radiotherapy: A Review of Modern Approaches
por: Nardone, Valerio, et al.
Publicado: (2022)

Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study
por: Nicosia, Luca, et al.
Publicado: (2020)

Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO)
por: Bonomo, Pierluigi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qipuvvl3lqbdf504dg5gmbq6l0